From http://projects.propublica.org/docdollars. © Copyright 2011 Pro Publica Inc.
Payments to Massachusetts Health Care Practitioners
This is a listing of all disclosed payments listed for Massachusetts
Only showing payments over $250. See all payments ยป
Important notes about this list.
Name/Payee includes both the practitioner listed by the company and the entity receiving payment. If only one name is listed, it represents both the listed practitioner and payee.
| Name / Payee | City | Company | Period | Category | Amount |
|---|---|---|---|---|---|
| HARVARD CLINICAL RESEARCH INSTITUTE | BOSTON | Eli Lilly | 2011 Q1 | Research | $767,564 |
| BAYSTATE MEDICAL CENTER | SPRINGFIELD | Pfizer | 2009 Q3-Q4 | Research | $19,093 |
| BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $7,544 |
| CARITAS ST. ELIZABETH'S MEDICAL CENTER | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $2,500 |
| CHILDREN'S HOSPITAL BOSTON | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $21,295 |
| DANA-FARBER/PARTNERS CANCER CARE INC | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $617,549 |
| GENERAL HOSPITAL CORPORATION | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $1,688 |
| MASSACHUSETTS EYE AND EAR INFIRMARY | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $7,330 |
| MASSACHUSETTS GENERAL HOSPITAL | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $1,539 |
| MCLEAN HOSPITAL | BELMONT | Pfizer | 2009 Q3-Q4 | Research | $4,531 |
| THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $21,541 |
| THE GENERAL HOSPITAL CORPORATION | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $4,863 |
| TRUSTEES OF BOSTON UNIVERSITY | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $5,235 |
| TUFTS MEDICAL CENTER | BOSTON | Pfizer | 2009 Q3-Q4 | Research | $42,895 |
| UNIVERSITY OF MASS MEDICAL CENTER | WORCESTER | Pfizer | 2009 Q3-Q4 | Research | $28,995 |
| UNIVERSITY OF MASSACHUSETTS | WORCESTER | Pfizer | 2009 Q3-Q4 | Research | $8,737 |
| UNIVERSITY OF MASSACHUSETTS WORCESTER | WORCESTER | Pfizer | 2010 Q1-Q4 | Research | $5,500 |
| UNIVERSITY OF MASSACHUSETTS | WORCESTER | Pfizer | 2010 Q1-Q4 | Research | $88,011 |
| UNIVERSITY OF MASS MEDICAL CENTER | WORCESTER | Pfizer | 2010 Q1-Q4 | Research | $4,120 |
| TUFTS UNIVERSITY | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $60,323 |
| TRUSTEES OF BOSTON UNIVERSITY | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $216,945 |
| THE GENERAL HOSPITAL CORPORATION | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $3,038 |
| NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $6,343 |
| MCLEAN HOSPITAL | BELMONT | Pfizer | 2010 Q1-Q4 | Research | $5,188 |
| MASSACHUSETTS GENERAL HOSPITAL | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $608,153 |
| MASSACHUSETTS EYE AND EAR INFIRMARY, HARVARD UNIVERSITY | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $16,748 |
| MA GENERAL HOSPITAL CORPORATION | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $26,294 |
| GENERAL HOSPITAL CORPORATION | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $13,042 |
| EDJ ASSOCIATES INC | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $19,354 |
| DANA-FARBER/PARTNERS CANCER CARE | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $1,260,735 |
| DANA-FARBER CANCER INSTITUTE | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $181,629 |
| CHILDREN'S HOSPITAL BOSTON | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $10,697 |
| BRIGHAM AND WOMEN'S HOSPITAL | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $358,296 |
| BOSTON UNIVERSITY | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $34,830 |
| BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $66,237 |
| BAYSTATE MEDICAL CENTER | SPRINGFIELD | Pfizer | 2010 Q1-Q4 | Research | $10,652 |
| TUFTS UNIVERSITY | BOSTON | Pfizer | 2011 Q1 | Research | $11,151 |
| TRUSTEES OF BOSTON UNIVERSITY | BOSTON | Pfizer | 2011 Q1 | Research | $875 |
| THE GENERAL HOSPITAL CORPORATION | BOSTON | Pfizer | 2011 Q1 | Research | $475 |
| NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY | BOSTON | Pfizer | 2011 Q1 | Research | $7,518 |
| MASSACHUSETTS GEN HOSPITAL | BOSTON | Pfizer | 2011 Q1 | Research | $19,330 |
| DANA-FARBER/PARTNERS CANCER CARE | BOSTON | Pfizer | 2011 Q1 | Research | $312,010 |
| CHILDREN'S HOSPITAL BOSTON | BOSTON | Pfizer | 2011 Q1 | Research | $850 |
| BRIGHAM AND WOMENS HOSPITAL | BOSTON | Pfizer | 2011 Q1 | Research | $39,031 |
| BOSTON UNIVERSITY | BOSTON | Pfizer | 2011 Q1 | Research | $21,606 |
| BETH ISRAEL DEASONESS MEDICAL CENTER | BOSTON | Pfizer | 2011 Q1 | Research | $24,381 |
| BAYSTATE MEDICAL CENTER | SPRINGFIELD | Pfizer | 2011 Q1 | Research | $931 |
| -, - | BOSTON | Eli Lilly | 2011 Q1 | Research | $372,235 |
| ABBASI, SHABBIR ABID | LAWRENCE | Allergan | 2010 Q3-Q4 | Combination | $1,001-$10,000 |
| Abraham, George | WORCESTER | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $7,000 |
| Abraham, George | WORCESTER | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $4,050 |
| Abraham, George | WORCESTER | GlaxoSmithKline | 2011 Q1 | Speaking | $2,000 |
| Abrahamson, Martin | BOSTON | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $350 |
| Abrahamson, Martin | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $400 |
| Abrahamson, Martin | BOSTON | GlaxoSmithKline | 2011 Q1 | Speaking | $400 |
| Abrahamson, Martin Julian | BOSTON | Merck | 2010 Q1-Q4 | Speaking | $5,500 |
| ABRAMSON, JEREMY / DANA FARBER CANCER INSTITUTE | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Research | $25,000 |
| ABRAMSON, MARTYN H | JAMAICA PLAIN | Pfizer | 2010 Q1-Q4 | Consulting | $3,517 |
| Afdahl, Nezam H / HARVARD MEDICAL FAC PHYS GRP | BOSTON | Merck | 2010 Q1-Q4 | Speaking | $7,800 |
| Afdhal, Nezam | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $400 |
| Afdhal, Nezam | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $4,200 |
| Aghassi, Payam | LEOMINSTER | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $7,500 |
| Aghassi, Payam | LEOMINSTER | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $3,000 |
| Ahuja, Angela / Angela Malik | CHELMSFORD | GlaxoSmithKline | 2011 Q1 | Speaking | $300 |
| AIELLO, LLOYD PAUL | BELMONT | Pfizer | 2009 Q3-Q4 | Consulting | $4,814 |
| AIELLO, LLOYD PAUL | BELMONT | Pfizer | 2009 Q3-Q4 | Travel | $1,172 |
| AIELLO, LLOYD PAUL | BELMONT | Pfizer | 2009 Q3-Q4 | Consulting | $1,100 |
| AIELLO, LLOYD PAUL | BELMONT | Pfizer | 2010 Q1-Q4 | Speaking | $6,314 |
| AIELLO, LLOYD PAUL | BELMONT | Pfizer | 2010 Q1-Q4 | Consulting | $3,500 |
| AIELLO, LLOYD PAUL | BOSTON | Pfizer | 2010 Q1-Q4 | Travel | $567 |
| AIELLO, LLOYD PAUL | BOSTON | Pfizer | 2010 Q1-Q4 | Consulting | $7,000 |
| AIKAWA, MASANORI | CHESTNUT HILL | Pfizer | 2009 Q3-Q4 | Speaking | $2,363 |
| AIKAWA, MASANORI | CHESTNUT HILL | Pfizer | 2009 Q3-Q4 | Meals | $1,144 |
| Al Mahameed, Amjad / Amjad AlMahameed | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $81,400 |
| ALI, MOUSTAFA M F / GENESIS CLINICAL RESEARCH & CONSULTING LLC | FALL RIVER | Pfizer | 2010 Q1-Q4 | Research | $36,317 |
| ALLEN, HOLLY / BAYSTATE MEDICAL CENTER INC DBA BAYSTATE MEDICAL CENTER | BOSTON | Eli Lilly | 2011 Q1 | Research | $675 |
| Almahameed, Amjad | BOSTON | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $51,700 |
| ALSTON, CYNTHIA E | LONGMEADOW | Pfizer | 2010 Q1-Q4 | Meals | $309 |
| Altman, Lee | Stoughton | AstraZeneca | 2010 Q1-Q4 | Speaking | $64,800 |
| Altman, Lee | Stoughton | AstraZeneca | 2011 Q1 | Speaking | $18,300 |
| ALTMAN, LEE S | QUINCY | Eli Lilly | 2010 Q1-Q4 | Speaking | $9,638 |
| ALTMAN, LEE S. | STOUGHTON | Eli Lilly | 2009 Q1-Q4 | Speaking | $13,200 |
| ALTSHULER, DAVID MATTHEW | BOSTON | Pfizer | 2010 Q1-Q4 | Travel | $416 |
| ALTSHULER, DAVID MATTHEW | BOSTON | Pfizer | 2010 Q1-Q4 | Meals | $470 |
| ANALORO, MARGARET GAIL | LYNN | Pfizer | 2010 Q1-Q4 | Meals | $265 |
| Andersen, Lori | BEDFORD | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $300 |
| Anderson, Kenneth / DANA-FARBER CANCER INSTITUTE | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $1,000 |
| Anderson, Kenneth | BOSTON | GlaxoSmithKline | 2011 Q1 | Consulting | $2,600 |
| ANDERSON, KENNETH | WELLESLEY | Eli Lilly | 2011 Q1 | Research | $3,500 |
| Anderson, Kenneth Carl | WELLESLEY | Merck | 2009 Q3-Q4 | Speaking | $3,000 |
| Andrade, Jorge | FALL RIVER | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $2,000 |
| Antin, Joseph | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $800 |
| ANTMAN, ELLIOTT MARSHALL | BOSTON | Pfizer | 2009 Q3-Q4 | Speaking | $2,000 |
| ANVERSA, PIERO | BOSTON | Pfizer | 2009 Q3-Q4 | Speaking | $2,000 |
| Apovian, Caroline | WABAN | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $3,250 |
| APPLEBY, LAURIE HELEN | BOSTON | Pfizer | 2009 Q3-Q4 | Speaking | $3,175 |
| APPLEBY, LAURIE HELEN | BOSTON | Pfizer | 2009 Q3-Q4 | Travel | $583 |
| Armstrong, Scott | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $1,000 |
| Arslanian, Armen / Beacon CLinical Research, LLC | Brockton | Cephalon | 2010 Q1-Q4 | Research | $14,694 |
| Arslanian, Armen / Beacon Clinical Research, Llc | Brockton | Cephalon | 2011 Q1-Q2 | Research | $47,108 |
| ASAKER, BAHIGE | BROCKTON | Pfizer | 2010 Q1-Q4 | Meals | $373 |
| Ashburn, Richard | Hanover | AstraZeneca | 2010 Q1-Q4 | Speaking | $4,800 |
| Ashburn, Richard | WEYMOUTH | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $14,800 |
| Ashburn, Richard | WEYMOUTH | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $6,000 |
| Ashburn, Richard | WEYMOUTH | GlaxoSmithKline | 2011 Q1 | Speaking | $6,250 |
| ATKINS, MICHAEL BENJ | BOSTON | Pfizer | 2009 Q3-Q4 | Consulting | $1,752 |
| ATKINS, MICHAEL BENJ | BOSTON | Pfizer | 2010 Q1-Q4 | Speaking | $5,000 |
| ATKINS, MICHAEL BENJ | BOSTON | Pfizer | 2010 Q1-Q4 | Travel | $11,524 |
| ATKINS, MICHAEL BENJ / MICHAEL B ATKINS | BOSTON | Pfizer | 2011 Q1 | Speaking | $2,039 |
| Audette, Joseph F. | Boston | Johnson & Johnson | 2010 Q1-Q4 | Speaking | $8,250 |
| August, Betsy | SALEM | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $3,250 |
| AUSTEN, K FRANK | BOSTON | Pfizer | 2010 Q1-Q4 | Consulting | $41,531 |
| AUSTEN, K FRANK | BOSTON | Pfizer | 2011 Q1 | Meals | $282 |
| AUSTEN, K FRANK | BOSTON | Pfizer | 2011 Q1 | Travel | $735 |
| AUSTEN, K FRANK | BOSTON | Pfizer | 2011 Q1 | Consulting | $17,649 |
| Bahnassi, Amjad | Worcester | AstraZeneca | 2010 Q1-Q4 | Speaking | $65,890 |
| Bahnassi, Amjad | Worcester | AstraZeneca | 2011 Q1 | Speaking | $1,600 |
| Bahnassi, Amjad | Worcester | AstraZeneca | 2011 Q1 | Speaking | $17,400 |
| Bahnassi, Amjad | WORCESTER | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $42,500 |
| BAHNASSI, AMJAD | WORCESTER | Novartis | 2010 Q4 | Speaking | $1,500 |
| BAHNASSI, AMJAD | WORCESTER | Pfizer | 2010 Q1-Q4 | Speaking | $5,750 |
| Baig, Mirza | FALL RIVER | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $4,000 |
| BAIG, MIRZA / INTERNAL MEDICINE & CARDIOLOGY | FALL RIVER | Eli Lilly | 2011 Q1 | Research | $899 |
| BAIG, MIRZA W | FALL RIVER | Eli Lilly | 2010 Q1-Q4 | Speaking | $2,634 |
| BAIG, MIRZA WAJID | FALL RIVER | Eli Lilly | 2009 Q1-Q4 | Speaking | $1,750 |
| BAISDEN, NICOLE F | LYNN | Pfizer | 2010 Q1-Q4 | Meals | $464 |
| Bajwa, Zahid | BOSTON | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $1,300 |
| BAJWA, ZAHID H. | BOSTON | Eli Lilly | 2009 Q1-Q4 | Speaking | $2,025 |
| BAJWA, ZAHID HUSSAIN | BROOKLINE | Pfizer | 2010 Q1-Q4 | Consulting | $1,300 |
| Baranovsky, Max | Chestnut Hill | AstraZeneca | 2010 Q1-Q4 | Speaking | $5,100 |
| Baranovsky, Max | Chestnut Hill | AstraZeneca | 2011 Q1 | Speaking | $1,700 |
| BARANOVSKY, MAX | BRIGHTON | Eli Lilly | 2011 Q1 | Travel | $766 |
| BARANOVSKY, MAX | BRIGHTON | Eli Lilly | 2011 Q1 | Speaking | $1,200 |
| BARANOVSKY, MAX | BRIGHTON | Eli Lilly | 2011 Q1 | Meals | $320 |
| BARANOVSKY, MAX | CHESTNUT HILL | Novartis | 2010 Q4 | Speaking | $1,600 |
| BARANOVSKY, MAX G | BRIGHTON | Pfizer | 2009 Q3-Q4 | Speaking | $1,000 |
| BARANOVSKY, MAX G | BRIGHTON | Pfizer | 2010 Q1-Q4 | Meals | $307 |
| Baranovsky, Max G. | Boston | Johnson & Johnson | 2010 Q1-Q4 | Speaking | $3,300 |
| BARDON, CHRISTIAN GOH | BOSTON | Pfizer | 2010 Q1-Q4 | Consulting | $307,538 |
| BARDON, CHRISTIAN GOH | BOSTON | Pfizer | 2011 Q1 | Consulting | $147,912 |
| BARKALOW, MARY ELIZABETH | SPRINGFIELD | Pfizer | 2010 Q1-Q4 | Meals | $457 |
| Basile, Frank | LOWELL | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $2,000 |
| Basile, Frank | LOWELL | GlaxoSmithKline | 2011 Q1 | Speaking | $2,000 |
| BATCHELOR, TRACY TODD / DANA-FARBER/PARTNERS CANCER CARE | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $161,122 |
| BATCHELOR, TRACY TODD / DANA-FARBER CANCER INSTITUTE | BOSTON | Pfizer | 2010 Q1-Q4 | Research | $35,329 |
| Bauer, Kenneth | JAMAICA PLAIN | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $10,000 |
| Bauer, Kenneth | JAMAICA PLAIN | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $34,000 |
| Bauer, Kenneth | JAMAICA PLAIN | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $5,500 |
| Bauer, Kenneth | JAMAICA PLAIN | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $12,500 |
| BAUER, KENNETH ALAN | JAMAICA PLAIN | Pfizer | 2010 Q1-Q4 | Travel | $5,407 |
| BAUER, KENNETH ALAN | JAMAICA PLAIN | Pfizer | 2010 Q1-Q4 | Meals | $271 |
| BAUER, KENNETH ALAN | JAMAICA PLAIN | Pfizer | 2010 Q1-Q4 | Consulting | $4,200 |
| Bayuk, Jonathan | Florence | AstraZeneca | 2010 Q1-Q4 | Speaking | $19,600 |
| Bayuk, Jonathan | Florence | AstraZeneca | 2011 Q1 | Speaking | $10,000 |
| Bayuk, Jonathan | FLORENCE | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $43,750 |
| Bayuk, Jonathan | FLORENCE | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $29,000 |
| Bayuk, Jonathan | FLORENCE | GlaxoSmithKline | 2011 Q1 | Speaking | $14,700 |
| BAYUK, JONATHAN L | NORTHAMPTON | Novartis | 2010 Q4 | Speaking | $7,500 |
| BENNETT, SOJA PARK | BOSTON | Pfizer | 2009 Q3-Q4 | Meals | $669 |
| BENNETT, SOJA PARK | BOSTON | Pfizer | 2009 Q3-Q4 | Travel | $905 |
| BENSON, CAROLYN ANN | WORCESTER | Pfizer | 2010 Q1-Q4 | Meals | $356 |
| Betancourt, Joseph R | CAMBRIDGE | Merck | 2009 Q3-Q4 | Speaking | $17,675 |
| Betancourt, Joseph R | CAMBRIDGE | Merck | 2010 Q1-Q4 | Speaking | $49,500 |
| Bhasin, Shalender | BOSTON | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $2,400 |
| Bhasin, Shalender | WESTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $4,000 |
| Bhasin, Shalender | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $4,000 |
| Bhatnagar, Nitin / Bhatnagar Enterprises | GREENFIELD | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $2,250 |
| Bhatt, Snehal | FRAMINGHAM | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $1,000 |
| BIBER, MICHAEL PETER / NEUROCARE INC | WEST ROXBURY | Pfizer | 2010 Q1-Q4 | Research | $21,139 |
| BIBER, MICHAEL PETER / NEUROLOGIA COGNITIVA RESEARCH LLC | BROOKLINE | Pfizer | 2011 Q1 | Research | $13,220 |
| BILL, ROSEMARY | STONEHAM | Eli Lilly | 2009 Q1-Q4 | Other | $2,138 |
| BILL, ROSEMARY | STONEHAM | Eli Lilly | 2010 Q1-Q4 | Other | $1,481 |
| BILLER, BEVERLY / GENERAL HOSPITAL CORP DBA MASSACHUSETTS GENERAL HOSPITAL | BOSTON | Eli Lilly | 2011 Q1 | Research | $6,496 |
| BILLER, BEVERLY M | CHARLESTOWN | Pfizer | 2009 Q3-Q4 | Consulting | $2,500 |
| BILLER, BEVERLY M | CHARLESTOWN | Pfizer | 2009 Q3-Q4 | Travel | $555 |
| BILLER, BEVERLY M / BILLER, BEVERLY M. | NEWTON | Pfizer | 2010 Q1-Q4 | Travel | $848 |
| BILLER, BEVERLY M | BOSTON | Pfizer | 2010 Q1-Q4 | Travel | $6,442 |
| BILLER, BEVERLY M | BOSTON | Pfizer | 2010 Q1-Q4 | Meals | $1,295 |
| BILLER, BEVERLY M | BOSTON | Pfizer | 2010 Q1-Q4 | Speaking | $3,500 |
| BILLER, BEVERLY M | BOSTON | Pfizer | 2010 Q1-Q4 | Consulting | $6,300 |
| BILLER, BEVERLY M | BOSTON | Pfizer | 2011 Q1 | Travel | $559 |
| BILLER, BEVERLY M | BOSTON | Pfizer | 2011 Q1 | Meals | $494 |
| Birbara, Charles | WORCESTER | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $1,500 |
| BIRBARA, CHARLES ALLEN / CLINICAL PHARMACOLOGY STUDY GROUP | WORCESTER | Pfizer | 2010 Q1-Q4 | Research | $223,830 |
| BIRBARA, CHARLES ALLEN / CLINICAL PHARMACOLOGY STUDY GROUP | WORCESTER | Pfizer | 2011 Q1 | Research | $40,221 |
| Birrer, Michael | BOSTON | GlaxoSmithKline | 2009 Q2-Q4 | Consulting | $1,500 |
| Birrer, Michael | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $1,600 |
| BISHOP, DUANE S | NEW BEDFORD | Pfizer | 2010 Q1-Q4 | Meals | $390 |
| BISHOP, DUANE S | NEW BEDFORD | Pfizer | 2010 Q1-Q4 | Travel | $456 |
| Blachman, Paul | WEYMOUTH | GlaxoSmithKline | 2009 Q2-Q4 | Speaking | $2,000 |
| Blachman, Paul | WEYMOUTH | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $4,300 |
| BLACHMAN, PAUL STEVEN | SOUTH WEYMOUTH | Pfizer | 2009 Q3-Q4 | Speaking | $1,000 |
| BLACK, BRUCE C. | WELLESLEY | Eli Lilly | 2009 Q1-Q4 | Speaking | $10,800 |
| Blauvelt, Barri / Innovara Inc. | HADLEY | GlaxoSmithKline | 2010 Q1-Q4 | Speaking | $3,000 |
| Blelloch, Robert | BOSTON | GlaxoSmithKline | 2010 Q1-Q4 | Consulting | $1,000 |
| Blinderman, Craig | Boston | Cephalon | 2010 Q1-Q4 | Speaking | $1,000 |
| Blinderman, Craig D | Boston | Cephalon | 2009 Q1-Q4 | Other | $4,500 |
| BODKIN, J ALEXANDER | BELMONT | Pfizer | 2009 Q3-Q4 | Consulting | $9,600 |
| BODKIN, J ALEXANDER | BELMONT | Pfizer | 2009 Q3-Q4 | Meals | $690 |
| BODKIN, J ALEXANDER | BELMONT | Pfizer | 2009 Q3-Q4 | Travel | $1,748 |
Notes
- Companies are continually updating their data, so the most recent additions may not be included in our database.
- The reports include both the name of the health provider who performed the service as well as the entity paid. They may be different.
- A physician on the list may be getting money from other companies that have yet to disclose payments.
- Practitioner names and addresses (city/state) are listed as the companies released them and may vary. For instance, some companies include a middle initial, and others do not. Some companies also list different cities for the same individual. This may happen because professionals may have practices in multiple locations or because they provided different addresses for payment.